Coming October 29: SITC releases its late-breaking abstract titles. We’ll add their presenting authors’ institutions to this guide once they’re out.

Palleon Pharmaceuticals at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Palleon Pharmaceuticals brings 2 presentations to SITC 2026 in Phoenix. Its program centres on HLX316, also known as E-688, a sialidase directed at B7-H3 that aims to boost innate and adaptive immunity against tumors. The work spans lab findings and a first-in-human study in advanced solid tumors.

OrganizationSITC 2026 Attendance
palleonpharma.com
Biotech
A biotechnology company developing therapies that target tumor-associated glycans to enhance antitumor immunity.
Poster
Fri Nov 6
12:15–1:45pm
5:30–7pm
Poster
Fri Nov 6
12:15–1:45pm
5:30–7pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Palleon Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction